$3.35
1.52% day before yesterday
Nasdaq, Dec 27, 10:16 pm CET
ISIN
US3741631036
Symbol
GERN
Sector
Industry

Geron Corporation Stock price

$3.35
-0.82 19.66% 1M
-1.09 24.55% 6M
+1.24 58.77% YTD
+1.17 53.67% 1Y
+2.03 153.79% 3Y
+1.97 142.75% 5Y
+0.05 1.36% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.05 1.52%
ISIN
US3741631036
Symbol
GERN
Sector
Industry

Key metrics

Market capitalization $2.03b
Enterprise Value $1.77b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 60.06
P/S ratio (TTM) P/S ratio 68.69
P/B ratio (TTM) P/B ratio 6.91
Revenue growth (TTM) Revenue growth 9,199.68%
Revenue (TTM) Revenue $29.48m
EBIT (operating result TTM) EBIT $-207.97m
Free Cash Flow (TTM) Free Cash Flow $-216.50m
Cash position $341.63m
EPS (TTM) EPS $-0.32
P/E forward negative
P/S forward 22.18
EV/Sales forward 19.39
Short interest 11.04%
Show more

Is Geron Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Geron Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Geron Corporation forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a Geron Corporation forecast:

Buy
100%

Financial data from Geron Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
29 29
9,113% 9,113%
100%
- Direct Costs 1.62 1.62
-
5%
28 28
-
95%
- Selling and Administrative Expenses 121 121
104% 104%
412%
- Research and Development Expense 113 113
6% 6%
384%
-207 -207
15% 15%
-702%
- Depreciation and Amortization 1.15 1.15
13% 13%
4%
EBIT (Operating Income) EBIT -208 -208
15% 15%
-705%
Net Profit -201 -201
15% 15%
-682%

In millions USD.

Don't miss a Thing! We will send you all news about Geron Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Geron Corporation Stock News

Neutral
Business Wire
9 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 72,000 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. The stock options were granted on December 18, 2...
Neutral
Business Wire
16 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of RYTELO (imetelstat) for the treatment o...
Neutral
Business Wire
19 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced results from an oral presentation at the 66th American Society of Hematology (ASH) Annual Meeting, reporting Phase 1 findings from the two-part IMproveMF study. The safety results from the dose escalat...
More Geron Corporation News

Company Profile

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Head office United States
CEO John Scarlett
Employees 141
Founded 1990
Website www.geron.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today